L01EA BCR-ABL tyrosine kinase inhibitors
ATC group of level 4 – chemical subgroup · in plain English: targeted cancer medicines (kinase inhibitors)
This site has the patient leaflet or the SPC of 101 medicines in this group and its subgroups.
Place in the ATC classification
How to read ATC codes – what the levels mean and what a code does not tell you.
- L Antineoplastic and immunomodulating agents 1,815 medicines
- L01 Antineoplastic agents 1,028 medicines
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 354 medicines
-
L01EA BCR-ABL tyrosine kinase inhibitors 101 medicines
- L01EA01 imatinib 22 medicines
- L01EA02 dasatinib 55 medicines
- L01EA03 nilotinib 8 medicines
- L01EA04 bosutinib 11 medicines
- L01EA05 ponatinib 5 medicines
-
L01EA BCR-ABL tyrosine kinase inhibitors 101 medicines
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 354 medicines
- L01 Antineoplastic agents 1,028 medicines
Medicines in the group and its subgroups
| Medicine | Legal category |
|---|---|
| Uxil 79 mg film-coated tablets no longer supplied (L01EA02 dasatinib) | – |
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L01EA
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.